Further pathway enrichment analysis revealed that SLC5A3 + tumor cells exhibit higher activity in pathways related to cholesterol metabolism, the PI3K-Akt signaling pathway, and the TGF-β signaling pathway (Fig. 9E). Here, SLC5A3 is linked to neoplasm.